These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24176092)

  • 1. Functional conservation of HIV-1 Gag: implications for rational drug design.
    Li G; Verheyen J; Rhee SY; Voet A; Vandamme AM; Theys K
    Retrovirology; 2013 Oct; 10():126. PubMed ID: 24176092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.
    Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance.
    Su CT; Kwoh CK; Verma CS; Gan SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4366-4377. PubMed ID: 29237328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors.
    Ghimire D; Kc Y; Timilsina U; Goel K; Nitz TJ; Wild CT; Gaur R
    Retrovirology; 2021 Apr; 18(1):9. PubMed ID: 33836787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gag sequence variation in a human immunodeficiency virus type 1 transmission cluster influences viral replication fitness.
    Gijsbers EF; van Nuenen AC; Schuitemaker H; Kootstra NA
    J Gen Virol; 2013 Feb; 94(Pt 2):354-359. PubMed ID: 23136365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variability in p6 gag protein and gag/pol coevolution in human immunodeficiency type 1 subtype F genomes.
    Rossi AH; Rocco CA; Mangano A; Sen L; Aulicino PC
    AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1056-60. PubMed ID: 23458243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
    Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T
    J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of amino acid variations in Gag and protease of HIV type 1 CRF01_AE strains on drug susceptibility of virus to protease inhibitors.
    Jinnopat P; Isarangkura-na-ayuthaya P; Utachee P; Kitagawa Y; de Silva UC; Siripanyaphinyo U; Kameoka Y; Tokunaga K; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):320-8. PubMed ID: 19727001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
    Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
    Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.
    Margot NA; Gibbs CS; Miller MD
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2345-53. PubMed ID: 20308382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of Conserved Residues in the Major Homology Region Arrest Assembling HIV-1 Gag as a Membrane-Targeted Intermediate Containing Genomic RNA and Cellular Proteins.
    Tanaka M; Robinson BA; Chutiraka K; Geary CD; Reed JC; Lingappa JR
    J Virol; 2016 Feb; 90(4):1944-63. PubMed ID: 26656702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa.
    Sharma S; Aralaguppe SG; Abrahams MR; Williamson C; Gray C; Balakrishnan P; Saravanan S; Murugavel KG; Solomon S; Ranga U
    BMC Infect Dis; 2017 Jan; 17(1):95. PubMed ID: 28118816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses.
    Claiborne DT; Prince JL; Hunter E
    J Vis Exp; 2014 Aug; (90):. PubMed ID: 25225725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients.
    Sakkhachornphop S; Hadpech S; Wisitponchai T; Panto C; Kantamala D; Utaipat U; Praparattanapan J; Kotarathitithum W; Taejaroenkul S; Yasamut U; Chupradit K; Moonmuang S; Sanghiran Lee V; Suparatpinyo K; Tayapiwatana C
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30428529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
    Ghimire D; Timilsina U; Srivastava TP; Gaur R
    Sci Rep; 2017 Mar; 7():43711. PubMed ID: 28252110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG.
    Ojesina AI; Chaplin B; Sankalé JL; Murphy R; Idigbe E; Adewole I; Ekong E; Idoko J; Kanki PJ
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1167-74. PubMed ID: 18729771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.